To assess whether the anti-tumour activity of PRMT5 inhibition observed for p53 wild-type models in vitro translates in vivo, we evaluated the efficacy of GSK3326595 in a p53 wild-type Z-138 xenograft model. Here, TP53 is linked to neoplasm.